DK105490C - Fremgangsmåde til fremstilling af et stafylokok-antigenprodukt i form af immunogene polysaccharidforbindelser. - Google Patents

Fremgangsmåde til fremstilling af et stafylokok-antigenprodukt i form af immunogene polysaccharidforbindelser.

Info

Publication number
DK105490C
DK105490C DK217262AA DK217262A DK105490C DK 105490 C DK105490 C DK 105490C DK 217262A A DK217262A A DK 217262AA DK 217262 A DK217262 A DK 217262A DK 105490 C DK105490 C DK 105490C
Authority
DK
Denmark
Prior art keywords
preparation
polysaccharide compounds
immunogenic polysaccharide
staphylococcal antigen
antigen product
Prior art date
Application number
DK217262AA
Other languages
Danish (da)
English (en)
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Application granted granted Critical
Publication of DK105490C publication Critical patent/DK105490C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/085Staphylococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK217262AA 1961-05-15 1962-05-14 Fremgangsmåde til fremstilling af et stafylokok-antigenprodukt i form af immunogene polysaccharidforbindelser. DK105490C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10997861A 1961-05-15 1961-05-15

Publications (1)

Publication Number Publication Date
DK105490C true DK105490C (da) 1966-10-03

Family

ID=22330610

Family Applications (1)

Application Number Title Priority Date Filing Date
DK217262AA DK105490C (da) 1961-05-15 1962-05-14 Fremgangsmåde til fremstilling af et stafylokok-antigenprodukt i form af immunogene polysaccharidforbindelser.

Country Status (6)

Country Link
CH (1) CH417852A (de)
DE (1) DE1185335B (de)
DK (1) DK105490C (de)
FI (1) FI40107C (de)
FR (1) FR2679M (de)
GB (1) GB992132A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5452794A (en) * 1977-09-30 1979-04-25 Kousaku Yoshida Extracting of polysacchride from capusle containing epidermis staphylococus
NZ216119A (en) * 1985-05-13 1989-01-06 Commw Scient Ind Res Org Vaccine produced using antigens of a pseudocapsule producing strain of s.aureus
IT1298539B1 (it) 1998-02-03 2000-01-12 Bracco Spa Metodo per la determinazione di infezioni da protesi
PT2493498T (pt) * 2009-10-30 2017-05-24 Glaxosmithkline Biologicals Sa Purificação de sacáridos capsulares de staphylococcus aureus tipo 5 e tipo 8
CN112694541B (zh) * 2020-12-26 2023-03-21 成都大学 一种黄蜀葵花多糖的温和脱色方法

Also Published As

Publication number Publication date
CH417852A (fr) 1966-07-31
FR2679M (fr) 1964-07-27
FI40107C (fi) 1968-10-10
DE1185335B (de) 1965-01-14
GB992132A (en) 1965-05-19
FI40107B (de) 1968-06-28

Similar Documents

Publication Publication Date Title
DK104694C (da) Fremgangsmåde til fremstilling af et briketteret rensemiddel.
DK104307C (da) Fremgangsmåde til fremstilling af et hexapeptid.
DK105490C (da) Fremgangsmåde til fremstilling af et stafylokok-antigenprodukt i form af immunogene polysaccharidforbindelser.
DK112161B (da) Fremgangsmåde til fremstilling af et gærpræparat til farmaceutisk anvendelse.
DK108971C (da) Fremgangsmåde til fremstilling af 6,17α -dimethylprogesteronderivater.
DK105825C (da) Fremgangsmåde til fremstilling af et desodoriseringsmiddel.
DK103317C (da) Fremgangsmåde til fremstilling af et langvarigt virkende gonadotropinpræparat.
DK116280B (da) Fremgangsmåde til fremstilling af 4,5-dehydro-3-keto-19-nor-steroider.
DK100356C (da) Fremgangsmåde til fremstilling af desferrioxaminer under anvendelse af en ferrioxaminproducerende mikroorganisme.
DK101508C (da) Fremgangsmåde til fremstilling af injicerbare pollen-antigenholdige præparater.
DK99169C (da) Fremgangsmåde til fremstilling af farmaceutisk sitosterinpræparater.
DK110220C (da) Fremgangsmåde til fremstilling af oxytetracyklin.
DK106326C (da) Fremgangsmåde til fremstilling af 5H-dibenzo-[a,d]-cycloheptener.
DK95476C (da) Fremgangsmåde til fremstilling af tertiære alkylferrocener.
GR23723B (el) Μεθοδος δια την παρασκευην ηρεμιστικων προιοντων.
DK94944C (da) Fremgangsmåde til fremstilling af 5-sulfanilamido-3-alkoxyalkyl-1,2,4-thiodiazoler.
DK88558C (da) Fremgangsmåde til fremstilling af 4,5-dehydro-β-apo-4-carotenal.
DK89152C (da) Fremgangsmåde til fremstilling af 4,5,6,7,10,10-heksaklor-4,7-endometylen-4,7,8,9-tetrahydroftalan.
DK91317C (da) Fremgangsmåde til fremstilling af 3,6-disulfonylchlorid-4-nitroanilin.
DK92544C (da) Fremgangsmåde til fremstilling af 1,2,3-triacyloleandomycin.
DK93233C (da) Fremgangsmåde til fremstilling af 5-sulfanilamido-3-benzyl-1,2,4-thiodiazoler.
DK98885C (da) Fremgangsmåde til fremstilling af 18,19-dinor-13-β-n-propyl-17α-ethinyl-testosteron.
DK94007C (da) Fremgangsmåde til fremstilling af et sennosid-carbonhydratpolymerkompleks.
DK100876C (da) Fremgangsmåde til fremstilling af 21-acyloxy-17α-hydroxy-16β-methyl-1,4,9-pregnatrien-3,20-dioner.
DK102203C (da) Fremgangsmåde til fremstilling af injicerbare præparater.